Answers are grounded in this paper and cite their sources.
The systemic inflammatory score (SIS), a new inflammatory marker based on a combination of the lymphocyte-to-monocyte ratio (LMR) and serum albumin concentration, has been reported to be a useful prognostic marker for several malignancies. The authors conducted this retrospective study on data from a cohort of esophageal cancer patients undergoing potentially curative resection to clarify the value of SIS as a prognostic marker for clinical outcome in this population.
No takes yet. Share an insight, caveat, or question.
Yoneda et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: